Garassino, Marina C
61  Ergebnisse:
Personensuche X
?
4

Treatment Characteristics and Real-World Progression-Free S..:

Girard, Nicolas ; Bar, Jair ; Garrido, Pilar...
https://research.rug.nl/en/publications/bb365b94-613a-4c92-9e5a-453545a119de.  , 2023
 
?
9

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalu..:

Spigel, David R ; Faivre-Finn, Corinne ; Gray, Jhanelle E...
Spigel , D R , Faivre-Finn , C , Gray , J E , Vicente , D , Planchard , D , Paz-Ares , L , Vansteenkiste , J F , Garassino , M C , Hui , R , Quantin , X , Rimner , A , Wu , Y-L , Özgüroğlu , M , Lee , K H , Kato , T , Wit , M D , Kurata , T , Reck , M , Cho , B C , Senan , S , Naidoo , J , Mann , H , Newton , M , Thiyagarajah , P & Antonia , S J 2022 , ' Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer ' , Journal of Clinical Oncology . https://doi.org/10.1200/JCO.21.01308.  , 2022
 
?
11

Four-Year Survival With Durvalumab After Chemoradiotherapy ..:

Faivre-Finn, Corinne ; Vicente, David ; Kurata, Takayasu...
Faivre-Finn , C , Vicente , D , Kurata , T , Planchard , D , Paz-Ares , L , Vansteenkiste , J F , Spigel , D R , Garassino , M C , Reck , M , Senan , S , Naidoo , J , Rimner , A , Wu , Y L , Gray , J E , Özgüroğlu , M , Lee , K H , Cho , B C , Kato , T , de Wit , M , Newton , M , Wang , L , Thiyagarajah , P & Antonia , S J 2021 , ' Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial ' , Journal of Thoracic Oncology , vol. 16 , no. 5 , pp. 860-867 . https://doi.org/10.1016/j.jtho.2020.12.015.  , 2021
 
?
12

On target: Rational approaches to KRAS inhibition for treat..:

Lindsay, Colin R ; Garassino, Marina C ; Nadal, Ernest...
Reproducció del document publicat a: https://doi.org/10.1016/j.lungcan.2021.07.005.  , 2021
 
?
 
?
15

Patient-reported outcomes with durvalumab by PD-L1 expressi..:

Garassino, Marina C ; Paz-Ares, Luis ; Hui, Rina...
Garassino , M C , Paz-Ares , L , Hui , R , Faivre-Finn , C , Spira , A , Planchard , D , Ozguroglu , M , Daniel , D , Vicente , D , Murakami , S , Langer , C , Senan , S , Spigel , D , Ryden , A , Zhang , Y , O'Brien , C , Dennis , P A & Antonia , S J 2021 , ' Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable, stage III non-small-cell lung cancer ' , Future Oncology , vol. 17 , no. 10 , pp. 1165-1184 . https://doi.org/10.2217/fon-2020-1102.  , 2021
 
1-15